System, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen

Device Code: 3560

Product Code(s): PEU

Definition: The [test] Is Intended For Use With Specimens From Patients For Whom There Is Clinical Suspicion Of Tuberculosis (TB) And Who Have Received No Antituberculosis Therapy, Or Less Than 3 Days Of Therapy. This [test] Is Intended As An Aid In The Diagnosi

Device Classification Information

Device Type ID3560
Device NameSystem, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen
Physical StateIn Vitro Diagnostic
Technical MethodNested Real-time PCR. The [test] Must Be Used In Conjunction With Mycobacterial Culture To Address The Risk Of False Negative Results And To Recover The Organisms For Further Characterization And Drug Susceptibility Testing. The [test] Should Only Be
Target AreaSputum
Regulation DescriptionNucleic Acid-based In Vitro Diagnostic Devices For The Detection Of Mycobacterium Tuberculosis Complex (MTB-complex) And The Genetic Mutations Associated With MTB-complex Antibiotic Resistance In Respiratory Specimens.
Regulation Medical SpecialtyMicrobiology
Review PanelMicrobiology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(k)
CFR Regulation Number866.3373 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodePEU
GMP ExemptNo
Summary MREligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID3560
DeviceSystem, Nucleic Acid-based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen
Product CodePEU
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionNucleic Acid-based In Vitro Diagnostic Devices For The Detection Of Mycobacterium Tuberculosis Complex (MTB-complex) And The Genetic Mutations Associated With MTB-complex Antibiotic Resistance In Respiratory Specimens.
CFR Regulation Number866.3373 [🔎]
Premarket Reviews
ManufacturerDecision
CEPHEID
 
SUBSTANTIALLY EQUIVALENT
1
TPLC Last Update: 2019-04-02 20:32:24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.